期刊： BREAST CANCER, 2021; 28 (4)
Breast cancer is a commonly diagnosed female cancer in the world. Triple-negative breast cancer (TNBC) is the most dangerous and biologically aggressi......
期刊： BREAST CANCER, 2021; 28 (5)
Aims Metaplastic breast cancer (MBC) comprises a heterogeneous group of tumors, of which MBC with osseous differentiation (MBC-OD) is extremely rare t......
Background Recent studies have indicated that serpin peptidase inhibitor, clade A, member 3 (SERPINA3) is a potential marker associated with tumor pro......
Background To summarize the clinicopathological characteristics, prognosis, and management of breast adenosquamous carcinoma (ASC). Methods A populati......
Background The optimal duration of endocrine therapy for patients with hormone receptor-positive (HR-positive) breast cancer is still unclear. This me......
Background BRCA1/2 gene mutation testing, based on next-generation sequencing (NGS), has been gradually applied in the clinic to serve as preventive e......
Background Accurate prediction of the outcome of breast cancer remains as a challenge due to its heterogeneous nature. We aimed to construct an immune......
Background MicroRNA-155 (miR-155) may function as a diagnostic biomarker of breast cancer (BC). Nevertheless, the available evidence is controversial.......
Background Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exos) exhibit various roles in breast cancer development. The molecular......
Purpose Somatic alteration of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) is a crucial therapeutic target in breas......
期刊： BREAST CANCER, 2020; 27 (4)
Background The burden of breast cancer has grown rapidly in China during recent decades. However, the association between tumor markers (CA15-3, CA125......
期刊： BREAST CANCER, 2020; 27 (2)
Purpose We performed a network meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of HER2-targeted agents in combination wi......
期刊： BREAST CANCER, 2020; 27 (4)
Objective To investigate the mechanism of miR-485-5p inhibiting breast cancer cells by targeting MUC1. Methods Differentially expressed genes (DEGs) i......
